XML 35 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Millions
Total
Share repurchase program
Total Nasdaq stockholders’ equity
Common stock
Additional paid-in capital
Additional paid-in capital
Share repurchase program
Additional paid-in capital
ASR agreement
 [2]
Common stock in treasury, at cost
Accumulated other comprehensive loss
Retained earnings
Retained earnings
Cumulative effect, period of adoption
Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2019       495,000,000                
Beginning balance at Dec. 31, 2019       $ 5 $ 2,629     $ (336) $ (1,686) $ 5,027 $ (12) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share repurchase program (in shares)           (6,000,000)            
Share repurchase program           $ (222)            
Share-based compensation (in shares)         3,000,000              
Share-based compensation         $ 87              
Stock option exercises, net         $ 2              
Other issuances of common stock, net (in shares) [1]         3,000,000              
Other issuances of common stock, net [1]         $ 48              
Other employee stock activity               (40)        
Other comprehensive income (loss) $ 318               318      
Net income attributable to Nasdaq $ 933                 933    
Cash dividends declared per common share                   (320)    
Net activity related to noncontrolling interests                       3
Ending balance (in shares) at Dec. 31, 2020 495,000,000     495,000,000                
Ending balance at Dec. 31, 2020 $ 6,436   $ 6,433 $ 5 $ 2,544     $ (376) (1,368) 5,628   3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13                      
Share repurchase program (in shares)           (9,000,000) (7,000,000)          
Share repurchase program           $ (468) $ (475)          
Share-based compensation (in shares)         3,000,000              
Share-based compensation         $ 90              
Stock option exercises, net         $ 1              
Other issuances of common stock, net (in shares) [1]         19,000,000              
Other issuances of common stock, net [1]         $ 257              
Other employee stock activity (in shares)               (1,000,000)        
Other employee stock activity               $ (61)        
Other comprehensive income (loss) $ (219)               (219)      
Net income attributable to Nasdaq $ 1,187                 1,187    
Cash dividends declared per common share                   (350)    
Net activity related to noncontrolling interests                       7
Ending balance (in shares) at Dec. 31, 2021 500,000,000     500,000,000                
Ending balance at Dec. 31, 2021 $ 6,405   6,395 $ 5 $ 1,949     $ (437) (1,587) 6,465   10
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share repurchase program (in shares)   (5,465,595)       (5,000,000) (6,000,000)          
Share repurchase program   $ (308)       $ (308) $ (325)          
Share-based compensation (in shares)         3,000,000              
Share-based compensation         $ 106              
Other issuances of common stock, net (in shares) [1]         1,000,000              
Other issuances of common stock, net [1]         $ 23              
Other employee stock activity (in shares)               (1,000,000)        
Other employee stock activity               $ (78)        
Other comprehensive income (loss) (404)               (404)      
Net income attributable to Nasdaq 1,123                 1,125    
Cash dividends declared per common share $ (383)                 (383)    
Net activity related to noncontrolling interests                       3
Ending balance (in shares) at Dec. 31, 2022 492,000,000                      
Ending balance at Dec. 31, 2022 $ 6,164   $ 6,151   $ 1,445     $ (515) $ (1,991) $ 7,207   $ 13
[1] In 2021, other issuances of common stock primarily related to shares accelerated and issued upon the sale of our U.S. Fixed Income business.
[2] See “ASR Agreement,” of Note 12, “Nasdaq Stockholders’ Equity,” for further discussion